Literature DB >> 29224086

Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.

Dongling Liu1, Xiang Zeng2, Xiao Li1, Jawahar L Mehta3, Xianwei Wang4.   

Abstract

NLRP3 inflammasome is a key multiprotein signaling platform that tightly controls inflammatory responses and coordinates antimicrobial host defenses by activating caspase-1 for the subsequent maturation of pro-inflammatory cytokines, IL-1β and IL-18, and induces pyroptosis. The assembly and activation of NLRP3 inflammasome are linked to the pathogenesis of several cardiovascular disease risk factors, such as hypertension and diabetes, and their major consequences-myocardial remodeling. The study of the NLRP3 inflammasome in these cardiovascular disease states may uncover important triggers and endogenous modulators of the disease, and lead to new treatment strategies. This review outlines current insights into NLRP3 inflammasome research associated with cardiovascular diseases and discusses the questions that remain in this field.

Entities:  

Keywords:  Cardiovascular diseases; Caspase-1; IL-1β; Inflammation; NLRP3 inflammasome

Mesh:

Substances:

Year:  2017        PMID: 29224086     DOI: 10.1007/s00395-017-0663-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  80 in total

1.  NR4A1 Promotes Cerebral Ischemia Reperfusion Injury by Repressing Mfn2-Mediated Mitophagy and Inactivating the MAPK-ERK-CREB Signaling Pathway.

Authors:  Zhanwei Zhang; Jianbai Yu
Journal:  Neurochem Res       Date:  2018-08-22       Impact factor: 3.996

2.  Macrophage-NLRP3 Inflammasome Activation Exacerbates Cardiac Dysfunction after Ischemic Stroke in a Mouse Model of Diabetes.

Authors:  Hong-Bin Lin; Guan-Shan Wei; Feng-Xian Li; Wen-Jing Guo; Pu Hong; Ya-Qian Weng; Qian-Qian Zhang; Shi-Yuan Xu; Wen-Bin Liang; Zhi-Jian You; Hong-Fei Zhang
Journal:  Neurosci Bull       Date:  2020-07-18       Impact factor: 5.203

3.  Effects of melatonin on acute brain reperfusion stress: role of Hippo signaling pathway and MFN2-related mitochondrial protection.

Authors:  Song Lan; Jingfang Liu; Xiangying Luo; Changlong Bi
Journal:  Cell Stress Chaperones       Date:  2019-01-10       Impact factor: 3.667

4.  Matrine has pro-apoptotic effects on liver cancer by triggering mitochondrial fission and activating Mst1-JNK signalling pathways.

Authors:  Jian Cao; Runjie Wei; Shukun Yao
Journal:  J Physiol Sci       Date:  2018-08-28       Impact factor: 2.781

5.  Blockade of the NLRP3 inflammasome improves metabolic health and lifespan in obese mice.

Authors:  Diego Cañadas-Lozano; Fabiola Marín-Aguilar; Beatriz Castejón-Vega; Bernhard Ryffel; José M Navarro-Pando; Jesús Ruiz-Cabello; Elísabet Alcocer-Gómez; Pedro Bullón; Mario D Cordero
Journal:  Geroscience       Date:  2020-01-23       Impact factor: 7.713

6.  Matrine promotes liver cancer cell apoptosis by inhibiting mitophagy and PINK1/Parkin pathways.

Authors:  Runjie Wei; Jian Cao; Shukun Yao
Journal:  Cell Stress Chaperones       Date:  2018-09-12       Impact factor: 3.667

Review 7.  The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation.

Authors:  Xiaolei Wang; Xiaohui Chen; Dobromir Dobrev; Na Li
Journal:  Pflugers Arch       Date:  2021-01-28       Impact factor: 3.657

8.  LncRNA MIAT downregulates IL-1β, TNF-ɑ to suppress macrophage inflammation but is suppressed by ATP-induced NLRP3 inflammasome activation.

Authors:  Ziye Wang; Yang Kun; Zhao Lei; Wen Dawei; Pan Lin; Wang Jibo
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

9.  DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.

Authors:  Yochai Birnbaum; Dat Tran; Mandeep Bajaj; Yumei Ye
Journal:  Basic Res Cardiol       Date:  2019-08-06       Impact factor: 17.165

10.  Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.

Authors:  Si-Lin Lv; Zi-Fan Zeng; Wen-Qiang Gan; Wei-Qi Wang; Tie-Gang Li; Yu-Fang Hou; Zheng Yan; Ri-Xin Zhang; Min Yang
Journal:  Acta Pharmacol Sin       Date:  2021-07-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.